Merck (MRK) Change in Inventory (2009)

Merck (MRK) reported Change in Inventory of -$1.1 billion for Q4 2009, down 831.08% quarter-over-quarter from $148.0 million in Q3 2009.

Merck (MRK) Change in Inventory (2009) Analysis & Trends

Merck (MRK) has 1 years of Change in Inventory data on file, last reported at -$1.1 billion in Q4 2009.

Change in Inventory for Q4 2009 came in at -$1.1 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2009 was -$370.0 million (changed N/A YoY), and the FY2025 annual result was $1.2 billion, up 41.32% from the prior year.
Change in Inventory slipped to -$1.1 billion in Q4 2009 per MRK's latest filing, from $148.0 million in the prior quarter.
Over five years, Change in Inventory peaked at $148.0 million in Q3 2009 and troughed at -$1.1 billion in Q4 2009.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Inventory (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	-
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	431.00 Mn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	184.00 Mn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	-
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	-18.00 Mn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	52.00 Mn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	-
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	-14.00 Mn
10	Novartis Ag	109.78 Bn	109.09 Bn	-	-95.00 Mn

Download Data